BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21394563)

  • 1. Comparative analysis of inactivated-state block of N-type (Ca(v)2.2) calcium channels.
    Vortherms TA; Swensen AM; Niforatos W; Limberis JT; Neelands TR; Janis RS; Thimmapaya R; Donnelly-Roberts DL; Namovic MT; Zhang D; Brent Putman C; Martin RL; Surowy CS; Jarvis MF; Scott VE
    Inflamm Res; 2011 Jul; 60(7):683-93. PubMed ID: 21394563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the substituted N-triazole oxindole TROX-1, a small-molecule, state-dependent inhibitor of Ca(V)2 calcium channels.
    Swensen AM; Herrington J; Bugianesi RM; Dai G; Haedo RJ; Ratliff KS; Smith MM; Warren VA; Arneric SP; Eduljee C; Parker D; Snutch TP; Hoyt SB; London C; Duffy JL; Kaczorowski GJ; McManus OB
    Mol Pharmacol; 2012 Mar; 81(3):488-97. PubMed ID: 22188924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence-based high-throughput screening assay for the identification of T-type calcium channel blockers.
    Belardetti F; Tringham E; Eduljee C; Jiang X; Dong H; Hendricson A; Shimizu Y; Janke DL; Parker D; Mezeyova J; Khawaja A; Pajouhesh H; Fraser RA; Arneric SP; Snutch TP
    Assay Drug Dev Technol; 2009 Jun; 7(3):266-80. PubMed ID: 19530894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of recombinant N-type calcium channel (Cav2.2) mediated calcium mobilization using FLIPR.
    Benjamin ER; Pruthi F; Olanrewaju S; Shan S; Hanway D; Liu X; Cerne R; Lavery D; Valenzano KJ; Woodward RM; Ilyin VI
    Biochem Pharmacol; 2006 Sep; 72(6):770-82. PubMed ID: 16844100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and characterization of a cell line with inducible expression of Ca(v)3.2 (T-type) channels.
    Xia M; Imredy JP; Santarelli VP; Liang HA; Condra CL; Bennett P; Koblan KS; Connolly TM
    Assay Drug Dev Technol; 2003 Oct; 1(5):637-45. PubMed ID: 15090236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.
    Sidach SS; Mintz IM
    J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effects of a substituted N-triazole oxindole (TROX-1), a state-dependent, voltage-gated calcium channel 2 blocker.
    Abbadie C; McManus OB; Sun SY; Bugianesi RM; Dai G; Haedo RJ; Herrington JB; Kaczorowski GJ; Smith MM; Swensen AM; Warren VA; Williams B; Arneric SP; Eduljee C; Snutch TP; Tringham EW; Jochnowitz N; Liang A; Euan MacIntyre D; McGowan E; Mistry S; White VV; Hoyt SB; London C; Lyons KA; Bunting PB; Volksdorf S; Duffy JL
    J Pharmacol Exp Ther; 2010 Aug; 334(2):545-55. PubMed ID: 20439438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+-dependent inactivation of CaV1.2 channels prevents Gd3+ block: does Ca2+ block the pore of inactivated channels?
    Babich O; Matveev V; Harris AL; Shirokov R
    J Gen Physiol; 2007 Jun; 129(6):477-83. PubMed ID: 17535960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967).
    Bezprozvanny I; Tsien RW
    Mol Pharmacol; 1995 Sep; 48(3):540-9. PubMed ID: 7565636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors.
    Dai G; Haedo RJ; Warren VA; Ratliff KS; Bugianesi RM; Rush A; Williams ME; Herrington J; Smith MM; McManus OB; Swensen AM
    Assay Drug Dev Technol; 2008 Apr; 6(2):195-212. PubMed ID: 18471074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-gated and Ca(2+)-activated K+ channels in intact human T lymphocytes. Noninvasive measurements of membrane currents, membrane potential, and intracellular calcium.
    Verheugen JA; Vijverberg HP; Oortgiesen M; Cahalan MD
    J Gen Physiol; 1995 Jun; 105(6):765-94. PubMed ID: 7561743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of N-, Q- and R-type Ca2+ channels in feedback inhibition of ACh release from rat basal forebrain neurones.
    Allen TG
    J Physiol; 1999 Feb; 515 ( Pt 1)(Pt 1):93-107. PubMed ID: 9925881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ca2+ and Na+ permeability of high-threshold Ca2+ channels and their voltage-dependent block by Mg2+ ions in chick sensory neurones.
    Carbone E; Lux HD; Carabelli V; Aicardi G; Zucker H
    J Physiol; 1997 Oct; 504 ( Pt 1)(Pt 1):1-15. PubMed ID: 9350613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a secondary screening assay for P/Q-type calcium channel blockers.
    Hermann D; Mezler M; Swensen AM; Bruehl C; Obergrußerger A; Wicke K; Schoemaker H; Gross G; Draguhn A; Nimmrich V
    Comb Chem High Throughput Screen; 2013 Mar; 16(3):233-43. PubMed ID: 23228050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An automated electrophysiological assay for differentiating Ca(v)2.2 inhibitors based on state dependence and kinetics.
    Swensen AM; Niforatos W; Vortherms TA; Perner RJ; Li T; Schrimpf MR; Scott VE; Lee L; Jarvis MF; McGaraughty S
    Assay Drug Dev Technol; 2012 Dec; 10(6):542-50. PubMed ID: 22428804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of human CaV3 channels by the diuretic amiloride.
    Lopez-Charcas O; Rivera M; Gomora JC
    Mol Pharmacol; 2012 Oct; 82(4):658-67. PubMed ID: 22767612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of endogenous N- and P/Q-type Ca2+ channel inactivation by Ca2+/calmodulin impacts on their ability to support exocytosis in chromaffin cells.
    Wykes RC; Bauer CS; Khan SU; Weiss JL; Seward EP
    J Neurosci; 2007 May; 27(19):5236-48. PubMed ID: 17494710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-affinity blockade of neuronal N-type Ca channels by the spider toxin omega-agatoxin-IVA.
    Sidach SS; Mintz IM
    J Neurosci; 2000 Oct; 20(19):7174-82. PubMed ID: 11007873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mibefradil on voltage-dependent gating and kinetics of T-type Ca(2+) channels in cortisol-secreting cells.
    Gomora JC; Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2000 Jan; 292(1):96-103. PubMed ID: 10604935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State-dependent inhibition of L-type calcium channels: cell-based assay in high-throughput format.
    Xia M; Imredy JP; Koblan KS; Bennett P; Connolly TM
    Anal Biochem; 2004 Apr; 327(1):74-81. PubMed ID: 15033513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.